Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Continuous Renal Replacement Therapy, Impact on Intensive Care Unit Length of Stay

NCT: NCT07586059 · NOT_YET_RECRUITING

NCT IDNCT07586059
StatusNOT_YET_RECRUITING
Start Date2026-08-01
Completion2026-12-31

Brief Summary

This large national cohort study, including over 500,000 patients, where around 5% are treated with continuous renal replacement therapy (CRRT) , aims to evaluate the association between time to initiation of CRRT and intensive care unit (ICU) length of stay (LOS).

Frequently Asked Questions

What is Continuous Renal Replacement Therapy, Impact on Intensive Care Unit Length of Stay?

Continuous Renal Replacement Therapy, Impact on Intensive Care Unit Length of Stay is a clinical trial registered under NCT07586059. Current status: NOT_YET_RECRUITING.

What is the status of NCT07586059?

The current status of NCT07586059 (Continuous Renal Replacement Therapy, Impact on Intensive Care Unit Length of Stay) is: NOT_YET_RECRUITING.

When did Continuous Renal Replacement Therapy, Impact on Intensive Care Unit Length of Stay start?

Continuous Renal Replacement Therapy, Impact on Intensive Care Unit Length of Stay started on 2026-08-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑